Standard Consent for Psychiatric Screening
Patients will first be contacted by phone or mail in order to determine preliminary eligibility. Patients will then be scheduled for an evaluation at the Mood Disorders Clinic. As part of the assessment, psychiatric ratings scales to measure the severity of the participants[Right Quote] depression may be administered. These scales measure depressive symptoms, including sleep difficulties, gain or loss in appetite and problems with concentration. Participants may be asked to undergo laboratory testing and/or to provide information regarding their psychiatric and medical history. Lab testing may consist of any of the following: physical exam, blood tests, a urine sample, or ECG. During the evaluation, if it is determined that stabilization or modification of a participant[Right Quote]s current treatment plan for a medical condition is needed, we will advise the participant to pursue this treatment modification with their treating physician. The research physicians are willing to consult with the participant[Right Quote]s treating physician as necessary with his/her consent.
Patients will be considered for this screening process if they are between the ages of 18 and 65 and appear to meet general criteria regarding the diagnosis required and medical health for any studies involving anxiety and depression. Patients may be referred to this study / MDRPC via a telephone screening, receipt of a completed packet of written information from the potential study participant, or by referral from a physician. Since each study for which a participant may be eligible will likely have different criteria for inclusion, the general screening procedure is much less restrictive regarding the patients who may be accepted for evaluation.